SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (269)3/23/1998 4:45:00 PM
From: SnowShredder  Read Replies (1) of 4474
 
Dr.Anderson is director of Gene Therapy Laboratories and a professor @ USC. He was the head of NIH for a # of years and is the editor-in-chief of Human Gene Therapy. I believe that he was one of the 1st to use the techniques of exvivo gene therapy (taking cells from the body, infecting them with virus, putting the infected/transduced cells back into the body). Basically, he is a big wig in the field. I think he founded GTI...which was bought out by Novartis.

@ the conference he basically said that he was going to pursue the goal of being a pioneer in inutero gene therapy.

I hope this helps.

Best of luck,

Where'd He Go?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News